References
- TamaokiTNomotoHTakahashiIKatoYMorimotoMTomitaFStaurosporine, a potent inhibitor of phospholipid/Ca++dependent protein kinaseBiochem Biophys Res Commun198613523974023457562
- ZhangXDGillespieSKHerseyPStaurosporine induces apoptosis of melanoma by both caspase-dependent and -independent apoptotic pathwaysMol Cancer Ther20043218719714985459
- SchwartzGKRedwoodSMOhnumaTHollandJFDrollerMJLiuBCInhibition of invasion of invasive human bladder carcinoma cells by protein kinase C inhibitor staurosporineJ Natl Cancer Inst19908222175317562231770
- TangDLahtiJMKiddVJCaspase-8 activation and bid cleavage contribute to MCF7 cellular execution in a caspase-3-dependent manner during staurosporine-mediated apoptosisJ Biol Chem2000275139303930710734071
- BaltuchGHDooleyNPCouldwellWTYongVWStaurosporine differentially inhibits glioma versus non-glioma cell linesJ Neurooncol19931621411478289091
- FuseETaniiHKurataNUnpredicted clinical pharmacology of UCN-01 caused by specific binding to human alpha1-acid glycoproteinCancer Res19985815324832539699650
- AkinagaSGomiKMorimotoMTamaokiTOkabeMAntitumor activity of UCN-01, a selective inhibitor of protein kinase C, in murine and human tumor modelsCancer Res19915118488848921893379
- GurleyLRUmbargerKOKimJMBradburyEMLehnertBEStaurosporine Analysis and its Pharmacokinetics in the Blood of RatsLos Alamos, NMLos Alamos National Laboratory1994
- GescherAAnalogs of staurosporine: potential anticancer drugs?Gen Pharmacol19983157217289809468
- JarvisWDGrantSProtein kinase C targeting in antineoplastic treatment strategiesInvest New Drugs199917322724010665476
- TestaJRBellacosaAAKT plays a central role in tumorigenesisProc Natl Acad Sci U S A20019820109831098511572954
- VivancoISawyersCLThe phosphatidylinositol 3-Kinase AKT pathway in human cancerNat Rev Cancer20022748950112094235
- SatoSFujitaNTsuruoTInterference with PDK1-Akt survival signaling pathway by UCN-01 (7-hydroxystaurosporine)Oncogene200221111727173811896604
- BaldwinRMParolinDALorimerIARegulation of glioblastoma cell invasion by PKC iota and RhoBOncogene200827253587359518212741
- LawrieAMNobleMETunnahPBrownNRJohnsonLNEndicottJAProtein kinase inhibition by staurosporine revealed in details of the molecular interaction with CDK2Nat Struct Biol19974107968019334743
- FriedmanBFujikiHRosnerMRRegulation of the epidermal growth factor receptor by growth-modulating agents: effects of staurosporine, a protein kinase inhibitorCancer Res19905035335381688732
- da RochaABMansDRRegnerASchwartsmannGTargeting protein kinase C: new therapeutic opportunities against high-grade malignant gliomas?Oncologist200271173311854544
- FischerUJänickeRUSchulze-OsthoffKMany cuts to ruin: a comprehensive update of caspase substratesCell Death Differ20031017610012655297
- PorterAGJänickeRUEmerging roles of caspase-3 in apoptosisCell Death Differ1999629910410200555
- AffarEBGermainMWinstallECaspase-3-mediated processing of poly(ADP-ribose) glycohydrolase during apoptosisJ Biol Chem200127642935294211053413
- DrummondDCMeyerOHongKKirpotinDBPapahadjopoulosDOptimizing liposomes for delivery of chemotherapeutic agents to solid tumorsPharmacol Rev199951469174310581328
- AllenTMCullisPRDrug delivery systems: entering the mainstreamScience200430356651818182215031496
- GabizonACataneRUzielyBProlonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomesCancer Res19945449879928313389
- GabizonAAStealth liposomes and tumor targeting: one step further in the quest for the magic bulletClin Cancer Res20017222322511234871
- WangAZLangerRFarokhzadOCNanoparticle delivery of cancer drugsAnnu Rev Med20126318519821888516
- RuoslahtiESpecialization of tumour vasculatureNat Rev Cancer200222839012635171
- BrownJMGiacciaAJThe unique physiology of solid tumors: opportunities (and problems) for cancer therapyCancer Res1998587140814169537241
- TschaikowskyKProtein kinase C inhibitors suppress LPS-induced TNF production in alveolar macrophages and in whole blood: the role of encapsulation into liposomesBiochim Biophys Acta1994122211131218186258
- YamauchiMKusanoHNakakuraMKatoYReducing the impact of binding of UCN-01 to human alpha1-acid glycoprotein by encapsulation in liposomesBiol Pharm Bull20052871259126415997110
- YostSEPastorinoSRozenzhakSHigh-resolution mutational profiling suggests the genetic validity of glioblastoma patient-derived pre-clinical modelsPLoS One201382e5618523441165
- MurphyEAMajetiBKMukthavaramRAcevedoLMBarnesLAChereshDATargeted nanogels: a versatile platform for drug delivery to tumorsMol Cancer Ther201110697298221518727
- HewavitharanaAKShawPNNgYKFuerstJASimple screening method for staurosporine in bacterial cultures using liquid chromatography-tandem mass spectrometryJ Bioanal Biomed200911001004
- GurleyLRUmbargerKOKimJMBradburyEMLehnertBEDevelopment of a high-performance liquid chromatographic method for the analysis of staurosporineJ Chromatogr B Biomed Appl199567011251387493070
- CharroisGJAllenTMDrug release rate influences the pharmacokinetics, biodistribution, therapeutic activity, and toxicity of pegylated liposomal doxorubicin formulations in murine breast cancerBiochim Biophys Acta200416631–216717715157619
- KurataNKuramitsuTTaniiHDevelopment of a highly sensitive high-performance liquid chromatographic method for measuring an anticancer drug, UCN-01, in human plasma or urineJ Chromatogr B Biomed Sci Appl19987081–22232279653966
- WakimotoHKesariSFarrellCJHuman glioblastoma-derived cancer stem cells: establishment of invasive glioma models and treatment with oncolytic herpes simplex virus vectorsCancer Res20096983472348119351838
- RajeshMSenJSrujanMMukherjeeKSreedharBChaudhuriADramatic influence of the orientation of linker between hydrophilic and hydrophobic lipid moiety in liposomal gene deliveryJ Am Chem Soc200712937114081142017718562
- PageBPageMNoelCA new fluorometric assay for cytotoxicity measurements in-vitroInt J Oncol19933347347621573387
- JensenMMJørgensenJTBinderupTKjaerATumor volume in subcutaneous mouse xenografts measured by microCT is more accurate and reproducible than determined by 18F-FDG-microPET or external caliperBMC Med Imaging200881618925932
- GurleyLRUmbargerKOKimJMBradburyEMLehnertBEHigh-performance liquid chromatographic analysis of staurosporine in vivo. Its translocation and pharmacokinetics in ratsJ Chromatogr B Biomed Sci Appl19987121–22112249698244
- FuseETaniiHTakaiKAltered pharmacokinetics of a novel anticancer drug, UCN-01, caused by specific high affinity binding to alpha1-acid glycoprotein in humansCancer Res19995951054106010070963
- HoffmanWPNessDKvan LierRBAnalysis of rodent growth data in toxicology studiesToxicol Sci200266231331911896298
- ClarkeSJFarrugiaDCAherneGWPritchardDMBensteadJJackmanALBalb/c mice as a preclinical model for raltitrexed-induced gastrointestinal toxicityClin Cancer Res20006128529610656460
- IwamotoHTorimuraTNakamuraTMetronomic S-1 chemotherapy and vandetanib: an efficacious and nontoxic treatment for hepatocellular carcinomaNeoplasia201113318719721390182
- ChangHIYehMKClinical development of liposome-based drugs: formulation, characterization, and therapeutic efficacyInt J Nanomedicine20127496022275822
- AndersonMOmriAThe effect of different lipid components on the in vitro stability and release kinetics of liposome formulationsDrug Deliv2004111333915168789
- ChangFLeeJTNavolanicPMInvolvement of PI3 K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapyLeukemia200317359060312646949
- MayoLDDonnerDBA phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleusProc Natl Acad Sci U S A20019820115981160311504915
- MurphyEAMajetiBKBarnesLANanoparticle-mediated drug delivery to tumor vasculature suppresses metastasisProc Natl Acad Sci U S A2008105279343934818607000
- TschaikowskyKBrainJDStaurosporine encapsulated into pH-sensitive liposomes reduces tnf production and increases survival in rat endotoxin shockShock1994164014077735968
- MunsonJMFriedLRowsonSAAnti-invasive adjuvant therapy with imipramine blue enhances chemotherapeutic efficacy against gliomaSci Transl Med20124127127ra36
- DrummondDCNobleCOGuoZHongKParkJWKirpotinDBDevelopment of a highly active nanoliposomal irinotecan using a novel intraliposomal stabilization strategyCancer Res20066663271327716540680
- StensrudGSandeSAKristensenSSmistadGFormulation and characterisation of primaquine loaded liposomes prepared by a pH gradient using experimental designInt J Pharm2000198221322810767570
- NiuGCogburnBHughesJPreparation and characterization of doxorubicin liposomesMethods Mol Biol201062421121920217598
- SadzukaYTakabeHSonobeTLiposomalization of SN-38 as active metabolite of CPT-11J Control Release20051082–345345916182400
- FernandesASGonçalvesAPCastroAModulation of fungal sensitivity to staurosporine by targeting proteins identified by transcriptional profilingFungal Genet Biol201148121130113822001288